The estimated Net Worth of Andrew Hykes is at least $54.8 Milion dollars as of 20 August 2024. Mr Hykes owns over 3,000 units of Inari Medical stock worth over $20,395,617 and over the last 4 years he sold NARI stock worth over $33,732,506. In addition, he makes $721,282 as Chief Operating Officer at Inari Medical.
Sign up
Mr Hykes NARI stock SEC Form 4 insiders trading
Mr has made over 43 trades of the Inari Medical stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 3,000 units of NARI stock worth $150,000 on 20 August 2024.
The largest trade he's ever made was exercising 430,517 units of Inari Medical stock on 12 March 2023 worth over $19,403,401. On average, Mr trades about 17,146 units every 28 days since 2020. As of 20 August 2024 he still owns at least 452,532 units of Inari Medical stock.
You can see the complete history of Mr Hykes stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Andrew J. Hykes biography
Andrew J. Hykes is the Chief Operating Officer at Inari Medical.
What is the salary of Mr Hykes?
As the Chief Operating Officer of Inari Medical, the total compensation of Mr Hykes at Inari Medical is $721,282. There are 2 executives at Inari Medical getting paid more, with William H. Hoffman having the highest compensation of $1,128,458.
How old is Mr Hykes?
Mr Hykes is 48, he's been the Chief Operating Officer of Inari Medical since . There are 3 older and no younger executives at Inari Medical. The oldest executive at Inari Medical, Inc. is Mitchell C. Hill, 62, who is the Chief Financial Officer.
What's Mr Hykes's mailing address?
Andrew's mailing address filed with the SEC is C/O INARI MEDICAL, INC., 6001 OAK CANYON, IRVINE, CA, 92618.
Insiders trading at Inari Medical
Over the last 4 years, insiders at Inari Medical have traded over $519,947,508 worth of Inari Medical stock and bought 1,100,480 units worth $22,863,324 . The most active insiders traders include Gilde Healthcare Iv U.A.Gil..., William Hoffman a Andrew Hykes. On average, Inari Medical executives and independent directors trade stock every 7 days with the average trade being worth of $1,998,809. The most recent stock trade was executed by Andrew Hykes on 20 August 2024, trading 3,000 units of NARI stock currently worth $150,000.
What does Inari Medical do?
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
What does Inari Medical's logo look like?
Complete history of Mr Hykes stock trades at Inari Medical
Inari Medical executives and stock owners
Inari Medical executives and other stock owners filed with the SEC include:
-
William H. Hoffman,
CEO, Pres & Director -
Dr. Thomas M. Tu M.D.,
Chief Medical Officer -
Andrew J. Hykes,
Chief Operating Officer -
John R. Borrell,
VP of Sales -
Eric Khairy,
VP Marketing -
Angela Ahmad,
Gen. Counsel -
Janet Byk,
VP of Fin. & Accounting -
Mitchell C. Hill,
Chief Financial Officer -
Robert Keith Warner,
Director -
Kirk G. Nielsen,
Director -
Jonathan D Root,
Director -
Dana G Jr. Mead,
Director -
Gilde Healthcare Iv U.A.Gil...,
-
Management Group X Llcus Ve...,
-
Catherine M. Szyman,
Director -
Management Group X Llcus Ve...,
-
Thomas Tu,
Chief Medical Officer -
Ventures Iv, Llc Versant Ve...,
-
Geoffrey B Pardo,
Director -
Mitch C. Hill,,
Chief Financial Officer -
Rebecca Chambers,
Director -
Cynthia L Lucchese,
Director -
William Hoffman,
Director -
Donald B Milder,
Director